Author response for "Human plasma‐derived alpha 1 ‐proteinase inhibitor in patients with new‐onset type 1 diabetes mellitus: a randomized, placebo‐controlled proof‐of‐concept study"

2020 ◽  
Author(s):  
William H. Lagarde ◽  
Kecia L. Courtney ◽  
Barry Reiner ◽  
Kimberly Steinmann ◽  
Eva Tsalikian ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Human Plasma ◽  
Proteinase Inhibitor ◽  
Author Response ◽  
Proof Of Concept ◽  
Concept Study ◽  
New Onset

Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study

The Lancet ◽  
2001 ◽  
Vol 357 (9253) ◽  
pp. 331-335 ◽  
Author(s):  
Jay S Skyler ◽  
William T Cefalu ◽  
Ione A Kourides ◽  
William H Landschulz ◽  
Cecile C Balagtas ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Human Insulin ◽  
Proof Of Concept ◽  
Concept Study

Modified release terbutaline (SKP1052) for hypoglycaemia prevention: a proof-of-concept study in people with type 1 diabetes mellitus

2012 ◽  
Vol 14 (12) ◽  
pp. 1137-1144
Author(s):  
L. Nosek ◽  
J.-M. Cardot ◽  
D. R. Owens ◽  
P. Ibarra ◽  
K. Bagate ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Modified Release ◽  
Proof Of Concept ◽  
Concept Study
Sign in / Sign up

Export Citation Format

Share Document